Qin Zhou

10PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumoursDiagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 14, 2026
Cost-effectiveness of adjuvant therapy with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma: from the perspective of the Chinese healthcare system.

|Jul 04, 2025
HDAC1/2-mediated deacetylation of KLF9 promotes the malignant progression of nasopharyngeal carcinoma via CDH17.

Kun Zhang, Xingzhi Peng, Peijun Zhou

|Jun 19, 2025
Ivonescimab plus chemotherapy in advanced or metastatic non‑squamous non‑small cell lung cancer with EGFR variant in China: a cost-effectiveness analysis.

Rong Long, Weilu Kuang, Qin Zhou

|Feb 24, 2024
Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1-2N0-1M0: A retrospective analysis.

Wenxi Wang, Yuxiang Wang, Wenhui Zeng

|Feb 18, 2024
Optimal sequence of LT for symptomatic BM in EGFR-mutant NSCLC: a comparative study of first-line EGFR-TKIs with/without upfront LT.

Lishui Niu, Honghua Wu, Ruihuan Gao

|Oct 17, 2023
Cost-effectiveness analysis of tislelizumab in combination with chemotherapy for the first-line treatment of patients with metastatic or recurrent nasopharyngeal carcinoma in China.

Yu-Kai Tang, Zhe Xu, Zhuo-Miao Ye

Pageof 2

Frequent Collaborators

1 joint publications

Zhanzhan Li

1 joint publications

Zhuo-Miao Ye

1 joint publications

Yu-Kai Tang

1 joint publications

Xiang-Ping Li